News from celsion corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 07, 2014, 08:00 ET

Celsion Corporation Reports Second Quarter 2014 Financial Results

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the second quarter ended June...

Jul 31, 2014, 08:00 ET

Celsion Corporation to Hold Second Quarter 2014 Financial Results

 Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss its second quarter 2014 financial...

Jul 28, 2014, 08:00 ET

Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox® in Primary Liver Cancer

 Celsion Corporation (NASDAQ: CLSN) today announced updated results from its retrospective analysis of the Company's 701-patient HEAT Study of...

Jul 24, 2014, 08:00 ET

Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer

Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in...

Jul 21, 2014, 08:00 ET

Celsion Corporation Announces $1 Million NIH, NIBIB - Career Development Award Grant for Glioblastoma Research with ThermoDox® and HIFU

Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that its ongoing collaboration with Dr. Costas...

Jul 15, 2014, 08:00 ET

Celsion Corporation Announces Commercialization of Reagent Products

 Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced initiation of sales of its proprietary...

Jul 14, 2014, 08:00 ET

Celsion Corporation to Ring the NASDAQ Stock Market Closing Bell on July 16, 2014

 Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that the Company will ring the NASDAQ Stock...

Jun 20, 2014, 09:00 ET

Celsion Corporation Completes Acquisition of EGEN, Inc.

Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, today announced the completion of the acquisition by Celsion of...

Jun 10, 2014, 10:00 ET

Celsion Closes Second $5 Million Tranche under Loan Facility Agreement with Hercules Technology Growth Capital

 Celsion Corporation (NASDAQ: CLSN) today announced that it has closed the second $5 million tranche under its $20 million Loan and Security...

Jun 10, 2014, 07:30 ET

Celsion Corporation to Acquire EGEN, Inc.

 Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical...

May 21, 2014, 08:00 ET

Celsion Advances Global Regulatory Efforts in Support of Pivotal Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer

 Celsion Corporation (NASDAQ: CLSN) today announced it has received regulatory clearance to initiate its Phase III OPTIMA Study at clinical...

May 16, 2014, 08:00 ET

Celsion Corporation Announces ThermoDox® Abstract Accepted at the 2014 American Society of Clinical Oncology 50th Annual Meeting

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that an abstract on its Phase III HEAT Study of...

May 08, 2014, 08:00 ET

Celsion Corporation Reports First Quarter 2014 Financial Results and Provides Business Update

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the first quarter ended March...

May 01, 2014, 08:00 ET

Celsion Corporation to Hold First Quarter 2014 Financial Results Conference Call on Thursday, May 8, 2014

 Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss first quarter 2014 financial...

Apr 24, 2014, 06:00 ET

Celsion Corporation Announces Updated Overall Survival Results from the HEAT Study of ThermoDox® in Primary Liver Cancer Presented at ECIO 2014

 Celsion Corporation (NASDAQ: CLSN) today announced that updated results from the 701 patient HEAT Study post-hoc analysis, as well as a review...

Apr 10, 2014, 08:00 ET

Celsion Announces ThermoDox® HCC Program to be discussed at the 2014 European Conference on Interventional Oncology in Berlin, Germany

Celsion Corporation (NASDAQ: CLSN) announced today that Professor Riccardo Lencioni, MD, FSIR, EBIR, Professor and Director of the Diagnostic...

Apr 09, 2014, 08:00 ET

Celsion's ThermoDox Plus High Intensity Focused Ultrasound Highlighted at 14th International Symposium on Therapeutic Ultrasound

Celsion Corporation (NASDAQ: CLSN) announced today that data supporting the development of ThermoDox®, its proprietary heat-activated...

Mar 13, 2014, 08:00 ET

Celsion Corporation Reports Year End 2013 Financial Results and Provides Business Update

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the year ended December 31,...

Mar 06, 2014, 08:00 ET

Celsion Corporation to Hold Year-End 2013 Financial Results Conference Call on Thursday, March 13, 2014

 Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss year-end 2013 financial results...

Feb 27, 2014, 16:05 ET

Celsion Announces Positive Interim Data from Phase 2 DIGNITY Trial in Breast Cancer

 Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox®...